Daily Bulletin

Men's Weekly

.

Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in Stage IV HER2-Positive Breast Cancer with Paxalisib Monotherapy

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

SYDNEY, Sept. 11, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced new findings from a collaborative research program led by Professor Sudha Rao at QIMR Berghofer.

In this ex vivo study, blood samples from Stage IV HER2-positive metastatic breast cancer (mBC) patients were...

Read more: Kazia Therapeutics Reports Complete Ex Vivo Disruption of Large Circulating Tumor Cell Clusters in...

Business News

Rising Demand: Why Melbourne Needs More Electricians Now

Melbourne is running on change. Rooftops are filling with solar, carports are getting charge points, and older switchboards are being rebuilt so homes and shops can carry smarter, heavier loads. If yo...

Daily Bulletin - avatar Daily Bulletin

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

How to Choose the Right Air Conditioner for Your Home or Business

In Australia’s climate, where summer heat can be intense and winter chills are felt in many regions, air conditioning has become more than just a luxury; it’s an essential part of comfortable living. ...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals